A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma

Howard L. Kaufman, William Conkright, Joseph Divito, Heidi Hörig, Ronald Kaleya, David Lee, Sridhar Mani, Dennis Panicali, Lakshmi Rajdev, T. S. Ravikumar, Susanne Wise-Campbell, Mark J. Surhland

Research output: Contribution to journalReview article

17 Scopus citations
Original languageEnglish (US)
Pages (from-to)1065-1082
Number of pages18
JournalHuman Gene Therapy
Volume11
Issue number7
DOIs
StatePublished - May 1 2000

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Kaufman, H. L., Conkright, W., Divito, J., Hörig, H., Kaleya, R., Lee, D., Mani, S., Panicali, D., Rajdev, L., Ravikumar, T. S., Wise-Campbell, S., & Surhland, M. J. (2000). A phase I trial of intra lesional RV-B7.1 vaccine in the treatment of malignant melanoma. Human Gene Therapy, 11(7), 1065-1082. https://doi.org/10.1089/10430340050015374